Share on StockTwits

Skyline Medical (NASDAQ:SKLN) CFO Robert L. Myers acquired 5,000 shares of Skyline Medical stock on the open market in a transaction dated Friday, August 22nd. The stock was purchased at an average cost of $0.15 per share, with a total value of $750.00. Following the completion of the acquisition, the chief financial officer now directly owns 5,000 shares in the company, valued at approximately $750. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Skyline Medical (NASDAQ:SKLN) traded down 10.10% during mid-day trading on Friday, hitting $0.1299. 40,115 shares of the company’s stock traded hands. Skyline Medical has a 1-year low of $0.106 and a 1-year high of $0.47. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.17. The company’s market cap is $29.0 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Receive News & Ratings for Skyline Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyline Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.